Taking back control: The experience of adults using semaglutide and tirzepatide for obesity treatment - A qualitative study.

ABSTRACT:

Background

Adequately treating obesity remains a fundamental goal for improving quality of life and long-term health outcomes. Semaglutide and tirzepatide have shown clinically meaningful weight loss in clinical trials, yet despite this weight loss efficacy, little is understood about how patients with obesity using semaglutide or tirzepatide experience making dietary behavior change. Furthermore, little is known about their perceptions of obesity treatment and healthcare provider interactions since taking the medications.

Methods

This was a basic qualitative study wherein adults with obesity taking semaglutide or tirzepatide participated in in-depth interviews and open-ended questionnaires. Participation criteria included a Body Mass Index (BMI) ≥ 30.0 kg/m², tak

SUBMITTER: Trocchio LL 

PROVIDER: S-EPMC12702257 | biostudies-literature | 2026 Mar

REPOSITORIES: biostudies-literature